Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life

Development of the HT&Me intervention to support women with breast cancer to adhere to adjuvant endocrine therapy and improve quality of life

Background: Breast cancer is the most common cancer in women worldwide. Approximately 80% of breast cancers are oestrogen receptor positive (ER+). Patients treated surgically are usually recommended adjuvant endocrine therapy (AET) for 5–10 years. AET significantly reduces recurrence, but up to 50%...

Full description

Bibliographic Details
Main Authors: Sarah-Jane F. Stewart, Joanna Slodkowska-Barabasz, Lucy McGeagh, Zoe Moon, Jo Brett, Mary Wells, Morven C. Brown, Mark Turner, Robert Horne, Deborah Fenlon, Farah Rehman, Henry Cain, Peter Donnelly, Victoria Harmer, Lesley Turner, Jan Rose, Linda Sharp, Eila Watson
Format: Article
Language:English
Published: Elsevier 2023-08-01
Series:Breast
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623005039

Internet

http://www.sciencedirect.com/science/article/pii/S0960977623005039

Similar Items